BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Elia G, Fallahi P, Ragusa F, Paparo SR, Mazzi V, Benvenga S, Antonelli A, Ferrari SM. Precision Medicine in Graves' Disease and Ophthalmopathy. Front Pharmacol 2021;12:754386. [PMID: 34776972 DOI: 10.3389/fphar.2021.754386] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Fallahi P, Ragusa F, Paparo SR, Elia G, Balestri E, Mazzi V, Patrizio A, Botrini C, Benvenga S, Ferrari SM, Antonelli A. Teprotumumab for the treatment of thyroid eye disease. Expert Opin Biol Ther 2023;:1-9. [PMID: 36695097 DOI: 10.1080/14712598.2023.2172328] [Reference Citation Analysis]
2 Huang J, Chen M, Liang Y, Hu Y, Xia W, Zhang Y, Zhao C, Wu L. Integrative metabolic analysis of orbital adipose/connective tissue in patients with thyroid-associated ophthalmopathy. Front Endocrinol 2022;13. [DOI: 10.3389/fendo.2022.1001349] [Reference Citation Analysis]
3 Zheng J, Duan H, You S, Liang B, Chen Y, Huang H. Research progress on the pathogenesis of Graves’ ophthalmopathy: Based on immunity, noncoding RNA and exosomes. Front Immunol 2022;13:952954. [DOI: 10.3389/fimmu.2022.952954] [Reference Citation Analysis]
4 Hu Y, Sun Y, Huang Y, Liu Q, Ren F, Li W. Serum Levels of CXCL-13, RBP-4, and IL-6, and Correlation Analysis of Patients with Graves’ Disease. Emergency Medicine International 2022;2022:1-6. [DOI: 10.1155/2022/5131846] [Reference Citation Analysis]
5 Umetsu A, Ida Y, Sato T, Watanabe M, Tsugeno Y, Furuhashi M, Hikage F, Ohguro H. Brimonidine Modulates the ROCK1 Signaling Effects on Adipogenic Differentiation in 2D and 3D 3T3-L1 Cells. Bioengineering 2022;9:327. [DOI: 10.3390/bioengineering9070327] [Reference Citation Analysis]
6 Gálvez BG, Martinez-Perez C, Villa-Collar C, Alvarez-Peregrina C, Sánchez-Tena MÁ. Influence of Cytokines on Inflammatory Eye Diseases: A Citation Network Study. J Clin Med 2022;11:661. [PMID: 35160111 DOI: 10.3390/jcm11030661] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]